Qiagen NV
QGEN43.900USD
-0.030-0.07%
Close 09/26, 16:00（ET）Quotes delayed by 15 min
9.52BMarket Cap
25.49P/E TTM
More Details of Company
Company Info
Ticker SymbolQGEN
Company nameQiagen NV
IPO dateSep 01, 1996
CEOMr. Thierry Bernard
Number of employees5765
Security typeOrdinary Share
Fiscal year-endSep 01
AddressHulsterweg 82
CityVENLO
Stock exchangeNYSE Consolidated
CountryNetherlands
Postal code5912 PL
Phone31773556600
Websitehttps://www.qiagen.com/
Ticker SymbolQGEN
IPO dateSep 01, 1996
CEOMr. Thierry Bernard
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Roland Sackers
Mr. Roland Sackers
Managing Director, Chief Financial Officer, Member of the Executive Board
Managing Director, Chief Financial Officer, Member of the Executive Board
383.09K
+59.93%
Mr. Thierry Bernard
Mr. Thierry Bernard
Chief Executive Officer, Managing Director, Member of the Executive Board
Chief Executive Officer, Managing Director, Member of the Executive Board
312.13K
+75.76%
Dr. Metin Colpan, Ph.D.
Dr. Metin Colpan, Ph.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
171.79K
-57.00%
Tallett (Elizabeth E)
Tallett (Elizabeth E)
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
47.22K
+10.37%
Prof. Dr. Ross L. Levine, M.D.
Prof. Dr. Ross L. Levine, M.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
16.27K
+30.83%
Prof. Dr. Elaine R. Mardis, Ph.D.
Prof. Dr. Elaine R. Mardis, Ph.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
3.97K
--
Mr. Stephen H. (Steve) Rusckowski
Mr. Stephen H. (Steve) Rusckowski
Independent Chairman of the Supervisory Board
Independent Chairman of the Supervisory Board
24.00
--
Ms. Eva van Pelt
Ms. Eva van Pelt
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Dr. Toralf Haag, Ph.D.
Dr. Toralf Haag, Ph.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Mr. Bert van Meurs
Mr. Bert van Meurs
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Roland Sackers
Mr. Roland Sackers
Managing Director, Chief Financial Officer, Member of the Executive Board
Managing Director, Chief Financial Officer, Member of the Executive Board
383.09K
+59.93%
Mr. Thierry Bernard
Mr. Thierry Bernard
Chief Executive Officer, Managing Director, Member of the Executive Board
Chief Executive Officer, Managing Director, Member of the Executive Board
312.13K
+75.76%
Dr. Metin Colpan, Ph.D.
Dr. Metin Colpan, Ph.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
171.79K
-57.00%
Tallett (Elizabeth E)
Tallett (Elizabeth E)
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
47.22K
+10.37%
Prof. Dr. Ross L. Levine, M.D.
Prof. Dr. Ross L. Levine, M.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
16.27K
+30.83%
Prof. Dr. Elaine R. Mardis, Ph.D.
Prof. Dr. Elaine R. Mardis, Ph.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
3.97K
--
Revenue Breakdown
Currency: USDUpdated: Sun, Jul 6
Currency: USDUpdated: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
By BusinessUSD
Name
Revenue
Proportion
Consumables and Related Revenues
435.06M
89.99%
Instrumentation
48.39M
10.01%
By RegionUSD
Name
Revenue
Proportion
United States
232.85M
48.16%
Europe & Middle East & Africa
160.64M
33.23%
Asia, Pacific & Rest of the World
68.83M
14.24%
Other Americas
21.13M
4.37%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Consumables and Related Revenues
435.06M
89.99%
Instrumentation
48.39M
10.01%
Shareholding Stats
Updated: Thu, Sep 11
Updated: Thu, Sep 11
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Wellington Management Company, LLP
12.00%
MFS Investment Management
10.83%
BlackRock Institutional Trust Company, N.A.
9.47%
The Vanguard Group, Inc.
4.22%
T. Rowe Price International Ltd
2.74%
Other
60.74%
Shareholders
Shareholders
Proportion
Wellington Management Company, LLP
12.00%
MFS Investment Management
10.83%
BlackRock Institutional Trust Company, N.A.
9.47%
The Vanguard Group, Inc.
4.22%
T. Rowe Price International Ltd
2.74%
Other
60.74%
Shareholder Types
Shareholders
Proportion
Investment Advisor/Hedge Fund
47.08%
Investment Advisor
32.87%
Research Firm
4.24%
Sovereign Wealth Fund
1.64%
Pension Fund
1.60%
Hedge Fund
1.43%
Holding Company
1.17%
Bank and Trust
1.02%
Individual Investor
0.44%
Other
8.50%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
996
189.55M
87.53%
+6.64M
2025Q1
1017
179.03M
82.67%
+27.58M
2024Q4
1010
129.03M
59.70%
-70.06M
2024Q3
1010
183.22M
84.72%
-23.62M
2024Q2
1002
184.34M
84.75%
+8.40M
2024Q1
988
165.20M
76.61%
-7.18M
2023Q4
993
165.11M
76.72%
-10.52M
2023Q3
987
159.93M
74.32%
-12.21M
2023Q2
996
162.43M
75.49%
-6.05M
2023Q1
1001
160.07M
74.44%
-9.45M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Wellington Management Company, LLP
24.44M
11.29%
+1.15M
+4.92%
Mar 31, 2025
MFS Investment Management
24.26M
11.2%
+24.26M
--
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
20.17M
9.31%
-350.47K
-1.71%
Jun 16, 2025
The Vanguard Group, Inc.
8.78M
4.06%
+245.16K
+2.87%
Mar 31, 2025
T. Rowe Price International Ltd
4.15M
1.92%
+4.01M
+2888.12%
Mar 31, 2025
EARNEST Partners, LLC
3.81M
1.76%
+3.81M
--
Mar 31, 2025
Amundi Asset Management, SAS
4.19M
1.94%
-516.05K
-10.96%
Mar 31, 2025
Swedbank Robur Fonder AB
3.06M
1.41%
+186.76K
+6.51%
May 31, 2025
Norges Bank Investment Management (NBIM)
3.96M
1.83%
-111.67K
-2.74%
Dec 31, 2024
View more
Related ETFs
Updated: Sat, Sep 6
Updated: Sat, Sep 6
Name
Proportion
ROBO Global Healthcare Technology & Innovation ETF
1.62%
Zacks Small/Mid Cap ETF
0.71%
Fidelity International Multifactor ETF
0.4%
iShares ESG Advanced MSCI EAFE ETF
0.12%
iShares MSCI World ETF
0.01%
iShares Russell 2500 ETF
0%
SPDR MSCI EAFE StrategicFactors ETF
0%
iShares MSCI ACWI ex U.S. ETF
0%
Vanguard ESG International Stock ETF
0%
Global X Genomics & Biotechnology ETF
0%
View more
ROBO Global Healthcare Technology & Innovation ETF
Proportion1.62%
Zacks Small/Mid Cap ETF
Proportion0.71%
Fidelity International Multifactor ETF
Proportion0.4%
iShares ESG Advanced MSCI EAFE ETF
Proportion0.12%
iShares MSCI World ETF
Proportion0.01%
iShares Russell 2500 ETF
Proportion0%
SPDR MSCI EAFE StrategicFactors ETF
Proportion0%
iShares MSCI ACWI ex U.S. ETF
Proportion0%
Vanguard ESG International Stock ETF
Proportion0%
Global X Genomics & Biotechnology ETF
Proportion0%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
Jan 17, 2025
Merger
36→35
Jan 17, 2025
Merger
36→35
Jan 17, 2025
Merger
36→35
Jan 17, 2025
Merger
36→35
Jan 18, 2024
Merger
25→24.25
Jan 18, 2024
Merger
25→24.25
Date
Type
Ratio
Jan 17, 2025
Merger
36→35
Jan 17, 2025
Merger
36→35
Jan 17, 2025
Merger
36→35
Jan 17, 2025
Merger
36→35
Jan 18, 2024
Merger
25→24.25
Jan 18, 2024
Merger
25→24.25
Jan 18, 2024
Merger
25→24.25
Jan 18, 2024
Merger
25→24.25
